Literature DB >> 18005990

Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.

Michael D W Griffin1, Melva L Y Mok, Leanne M Wilson, Chi L L Pham, Lynne J Waddington, Matthew A Perugini, Geoffrey J Howlett.   

Abstract

A common feature of many of the most important and prominent amyloid-forming proteins is their ability to bind lipids and lipid complexes. Lipids are ubiquitous components of disease-associated amyloid plaques and deposits in humans, yet the specific roles of lipid in the process of amyloid fibril formation are poorly understood. This study investigated the effect of phospholipids on amyloid fibril formation by human apolipoprotein (apo) C-II using phosphatidylcholine derivatives comprising acyl chains of up to 14 carbon atoms. Submicellar concentrations of short-chain phospholipids increase the rate of apoC-II fibril formation in an acyl-chain-length- and concentration-dependent fashion, while high micellar concentrations of phospholipids completely inhibited amyloid formation. At lower concentrations of soluble phospholipid complexes, fibril formation by apoC-II was only partially inhibited, and under these conditions, aggregation followed a two-phase process. Electron microscopy showed that the fibrils resulting from the second phase of aggregation were straight, cablelike, and about 13 nm wide, in contrast to the homogeneous twisted-ribbon morphology of apoC-II fibrils formed under lipid-free conditions. Seeding experiments showed that this alternative fibril structure could be templated both in the presence and in the absence of lipid complex, suggesting that the two morphologies result from distinct assembly pathways. Circular dichroism spectroscopy studies indicated that the secondary structural conformation within the straight-type and ribbon-type fibrils were distinct, further suggesting divergent assembly pathways. These studies show that phospholipid complexes can change the structural architecture of mature fibrils and generate new fibril morphologies with the potential to alter the in vivo behaviour of amyloid. Such lipid interactions may play a role in defining the structural features of fibrils formed by diverse amyloidogenic proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005990     DOI: 10.1016/j.jmb.2007.10.038

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

2.  Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.

Authors:  Timothy M Ryan; Chai L Teoh; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

3.  Tracking the heterogeneous distribution of amyloid spherulites and their population balance with free fibrils.

Authors:  V Foderà; A M Donald
Journal:  Eur Phys J E Soft Matter       Date:  2010-11-04       Impact factor: 1.890

4.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

5.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

Review 6.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

7.  Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I.

Authors:  Yuan Qi Wong; Katrina J Binger; Geoffrey J Howlett; Michael D W Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

8.  Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II.

Authors:  Timothy M Ryan; Geoffrey J Howlett; Michael F Bailey
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

9.  Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation?

Authors:  Andrew Hung; Michael D W Griffin; Geoffrey J Howlett; Irene Yarovsky
Journal:  Eur Biophys J       Date:  2008-09-04       Impact factor: 1.733

10.  Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.

Authors:  Timothy M Ryan; Michael D W Griffin; Duncan J McGillivray; Robert B Knott; Kathleen Wood; Colin L Masters; Nigel Kirby; Cyril C Curtain
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.